167 related articles for article (PubMed ID: 34430510)
1. 10-Year Experience with Reinforced Ureteral Stents for Malignant Ureteral Obstruction.
Vogt B; Blanchet LH
Res Rep Urol; 2021; 13():581-589. PubMed ID: 34430510
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Ureteral Tumour Stents for Malignant Ureteral Obstruction: Towards Reshaping an Optimal Stent.
Vogt B; Blanchet LH
Res Rep Urol; 2021; 13():773-782. PubMed ID: 34737982
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated with Ureteral Stent Failure in Patients with Malignant Ureteral Obstruction.
Pickersgill NA; Wahba BM; Vetter JM; Cope SJ; Barashi NS; Henning GM; Du K; Figenshau RS; Desai AC; Venkatesh R
J Endourol; 2022 Jun; 36(6):814-818. PubMed ID: 35018790
[No Abstract] [Full Text] [Related]
4. Use of full-length metallic stents in malignant ureteral obstruction.
Abbasi A; Wyre HW; Ogan K
J Endourol; 2013 May; 27(5):640-5. PubMed ID: 23237309
[TBL] [Abstract][Full Text] [Related]
5. Tandem ureteral stents for the decompression of malignant and benign obstructive uropathy.
Elsamra SE; Motato H; Moreira DM; Waingankar N; Friedlander JI; Weiss G; Smith AD; Okeke Z
J Endourol; 2013 Oct; 27(10):1297-302. PubMed ID: 23829600
[TBL] [Abstract][Full Text] [Related]
6. Tandem ureteral stents drainage lowers renal pelvis pressure in malignant ureteral obstruction: Experimental and computational models.
Haifler M; Kleinmann N; Weiss D
J Biomech; 2021 Mar; 117():110237. PubMed ID: 33486265
[TBL] [Abstract][Full Text] [Related]
7. Risk factors in the prediction of long-term patency of Resonance metallic ureteric stent in malignant ureteric obstruction.
Ho BSH; Chiu PKF; Lam W; Wong JHF; Wong CKW; Lai TCT; Tsang CF; Ng ATL; Chan CK; Ma WK; Ng CF; Tsu JHL
BJUI Compass; 2020 May; 1(2):74-81. PubMed ID: 35474710
[TBL] [Abstract][Full Text] [Related]
8. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
Matsuura H; Arase S; Hori Y
Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
[TBL] [Abstract][Full Text] [Related]
9. Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients.
Liu KL; Lee BC; Ye JD; Chang YH; Chang CC; Huang KH; Lee YJ; Chang YC
Eur Radiol; 2019 Feb; 29(2):628-635. PubMed ID: 29974220
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Follow-Up of Yearly Replaced Double Internal Stents for Extrinsic Malignant Ureteral Obstruction.
Savin Z; Herzberg H; Ben-David R; Dekalo S; Mintz I; Marom R; Barghouthy Y; Mano R; Yossepowitch O; Sofer M
J Endourol; 2021 Jan; 35(1):71-76. PubMed ID: 32668988
[No Abstract] [Full Text] [Related]
11. The Role of Tandem Double-J Ureteral Stents in the Management of Malignant Ureteral Obstruction.
Varnavas M; Bolgeri M; Mukhtar S; Anson K
J Endourol; 2016 Apr; 30(4):465-8. PubMed ID: 26585189
[TBL] [Abstract][Full Text] [Related]
12. Use of metallic and polymeric ureteral stents in malignant ureteral obstruction.
Ohtaka M; Kawahara T; Hayashi Y; Kobayashi R; Tsutsumi S; Ousaka K; Takizawa A; Kishida T; Yao M; Uemura H
BJUI Compass; 2021 Jan; 2(1):58-63. PubMed ID: 35474665
[TBL] [Abstract][Full Text] [Related]
13. Stiffness Analysis of Reinforced Ureteral Stents Against Radial Compression: In vitro Study.
Vogt B
Res Rep Urol; 2020; 12():583-591. PubMed ID: 33274188
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Stent Failure for Malignant Ureteral Obstruction in Non-Urological Cancer.
Heo JE; Jeon DY; Lee J; Han HH; Jang WS
Yonsei Med J; 2023 Nov; 64(11):665-669. PubMed ID: 37880847
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes and prognostic factors associated with internal ureteral stent placement for malignant extrinsic ureteral obstruction.
Matsuura H; Arase S; Hori Y
Support Care Cancer; 2020 Dec; 28(12):5743-5750. PubMed ID: 32206969
[TBL] [Abstract][Full Text] [Related]
16. It is Possible to Reduce Ureteral Stent Clogging and Stent-Related Symptoms to Soothe the Pain of the Patient: A Case Report.
Vogt B; Dove-Rumé J
Res Rep Urol; 2023; 15():315-319. PubMed ID: 37425651
[TBL] [Abstract][Full Text] [Related]
17. [The Predictive Factors of Stent Failure in the Treatment of Malignant Extrinsc Ureteral Obstruction Using Internal Ureteral Stents].
Matsuura H; Arase S; Hori Y; Tochigi H
Hinyokika Kiyo; 2017 Dec; 63(12):503-507. PubMed ID: 29370660
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
[TBL] [Abstract][Full Text] [Related]
19. Unveiling the Challenges in Tandem Ureteral Stent Management for Malignant Ureteral Obstruction: Failure Rate, Risk Factors, and Durability of Their Replacement.
Carmona O; Shvero A; Zilberman DE; Dotan ZA; Kleinmann N
J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629293
[TBL] [Abstract][Full Text] [Related]
20. Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.
Kim SH; Park B; Joo J; Joung JY; Seo HK; Chung J; Lee KH
PLoS One; 2017; 12(9):e0184965. PubMed ID: 28931043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]